Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
16.66B | 16.44B | 16.63B | 17.15B | 16.60B | 14.93B | Gross Profit |
3.65B | 3.51B | 3.46B | 3.46B | 3.57B | 3.11B | EBIT |
263.36M | 135.11M | 257.48M | 240.74M | 463.88M | 220.55M | EBITDA |
802.94M | 1.07B | 1.04B | 1.16B | 922.92M | 1.14B | Net Income Common Stockholders |
336.33M | 332.27M | 257.20M | 327.88M | 264.72M | 304.85M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
2.88B | 3.01B | 2.63B | 1.97B | 1.28B | 2.34B | Total Assets |
19.66B | 19.71B | 20.55B | 19.55B | 19.29B | 19.11B | Total Debt |
1.58B | 1.58B | 1.68B | 1.75B | 1.76B | 1.91B | Net Debt |
-1.30B | -1.43B | -945.82M | -216.41M | 473.72M | -426.14M | Total Liabilities |
7.83B | 7.77B | 8.41B | 8.55B | 8.56B | 8.50B | Stockholders Equity |
11.72B | 11.83B | 12.04B | 10.92B | 10.64B | 10.53B |
Cash Flow | Free Cash Flow | ||||
0.00 | 619.85M | 729.25M | 748.00M | -630.67M | -299.88M | Operating Cash Flow |
0.00 | 1.01B | 1.04B | 1.17B | 944.15M | 485.64M | Investing Cash Flow |
0.00 | -913.96M | -200.03M | -465.62M | -1.59B | -749.93M | Financing Cash Flow |
0.00 | -226.86M | -202.13M | -132.44M | -292.56M | -92.02M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥15.21B | 7.56 | 3.99% | 10.75% | 287.84% | ||
74 Outperform | ¥3.20B | 5.91 | 2.69% | 2.92% | -6.42% | ||
70 Outperform | ¥5.41B | 16.28 | 0.57% | -1.18% | 29.19% | ||
68 Neutral | ¥3.38B | 8.53 | 1.91% | -7.15% | 39.05% | ||
66 Neutral | $4.44B | 12.08 | 5.34% | 5.82% | 4.17% | -11.81% | |
64 Neutral | ¥4.03B | 57.17 | 3.80% | 0.38% | 24.47% | ||
58 Neutral | ¥27.50B | 60.98 | 1.48% | 2.92% | -74.66% |